Ernexa Therapeutics Inc has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on October 17, 2022 with the ratio of 1-for-20, meaning that for 20 shares of ERNA owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on May 04, 2026 on a 1-for-25 basis.
These splits have increased ERNA stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Ernexa Therapeutics Inc's total market capitalization.
For more detailed information of Ernexa Therapeutics Inc's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Ernexa Therapeutics Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when ERNA stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Ernexa Therapeutics Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
